RTU Gemcet 200mg Injection
Marketer
Aegis Oncology
Salt Composition
Gemcitabine (200mg)
Overview RTU Gemcet 200mg Injection
Gemcet 200mg Injection (Ready-to-Use) is indicated for treating several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is strictly via injection by a healthcare professional. Dosage and frequency are determined by your physician based on your specific condition and may vary. Always adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits might not be immediately apparent, potentially taking weeks or months. Discontinue use only under your doctor's guidance. Common side effects include nausea, vomiting, decreased appetite, alopecia, and thrombocytopenia. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid levels, are essential. Inform your physician of any pre-existing heart, liver, or kidney conditions, or the use of any antimicrobial medications before starting treatment. Drug interactions are possible; disclose all medications you're currently taking. This medication is contraindicated during pregnancy and breastfeeding. Employing effective contraception is crucial for both partners throughout the treatment period to prevent pregnancy.
Primary Ingredients of RTU Gemcet 200mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of RTU Gemcet 200mg Injection
Lung cancer (non-small cell), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of RTU Gemcet 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of RTU Gemcet 200mg Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use RTU Gemcet 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How RTU Gemcet 200mg Injection works:
Gemcet 200mg Injection (ready-to-use) disrupts cancer cell proliferation by replacing essential DNA and RNA components, thereby halting their growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemcet 200mg Injection and alcohol may result in heightened somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemcet 200mg Injection during pregnancy is contraindicated due to confirmed risk to the fetus. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the hazards. Seek medical advice before use.
Breast feedingUNSAFE
Administering Gemcet 200mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Gemcet 200mg Injection may cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemcet 200mg Injection (ready-to-use formulation) to individuals with renal impairment. Physician consultation is necessary. Pre-treatment and ongoing assessment of kidney function are recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Gemcet 200mg Injection (ready-to-use formulation) to individuals with hepatic impairment. Physician consultation is recommended.
What if you forget to take RTU Gemcet 200mg Injection :
NA
Facts to Know About RTU Gemcet 200mg Injection
| Label | Value |
|---|---|
| Chemical Type | Modified Cytosine |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Behavior Class | Metabolic Inhibitors |
3,018 People bought this recently